A detailed history of M&T Bank Corp transactions in Zai Lab LTD stock. As of the latest transaction made, M&T Bank Corp holds 23,704 shares of ZLAB stock, worth $410,790. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,704
Holding current value
$410,790
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$15.95 - $26.8 $378,078 - $635,267
23,704 New
23,704 $379,000
Q4 2021

Feb 07, 2022

SELL
$54.9 - $105.21 $111,172 - $213,050
-2,025 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$125.11 - $180.0 $13,386 - $19,260
-107 Reduced 5.02%
2,025 $358,000
Q1 2021

May 06, 2021

SELL
$126.27 - $191.71 $25,001 - $37,958
-198 Reduced 8.5%
2,132 $284,000
Q4 2020

Feb 12, 2021

BUY
$81.94 - $135.34 $190,920 - $315,342
2,330 New
2,330 $315,000
Q3 2020

Nov 06, 2020

SELL
$73.3 - $89.48 $230,308 - $281,146
-3,142 Closed
0 $0
Q2 2020

Jul 29, 2020

BUY
$48.82 - $82.53 $153,392 - $259,309
3,142 New
3,142 $258,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $1.7B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.